Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06808451 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 11, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Jan 31, 2026 to Sep 30, 2026v6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2025 to Oct 22, 2025
    • Site details revised
    v5
  3. Start date: Jul 1, 2025 to Oct 1, 2025
    • Primary and study completion dates: Oct 31, 2025 to Jan 31, 2026
    v4
  4. Start date: May 1, 2025 to Jul 1, 2025v3
  5. Start date: Mar 1, 2025 to May 1, 2025
    • Interventions: DNA PCR (Diagnostic Test), Urine Culture (Diagnostic Test) to DNA PCR (Device), Urine Culture (Diagnostic Test)
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adults 18 years or older with urinary tract infection (UTI) symptoms. Participants will be assigned to either the urine culture group or the DNA PCR study group by randomization. At time of enrollment in the study they will be also asked to fill out two questionnaires. If prescribed antibiotics for treatment of a UTI, participants will then be called the day after they are scheduled to stop their antibiotics. Participants will be asked to fill out questionnaires the day after finishing antibiotics. Participants will be enrolled in the study for a maximum of 21 days.
Trial Details
NCT Number NCT06808451
Lead Sponsor University Hospitals Cleveland Medical Center
Conditions
(from sponsor)		 Urinary Tract Infections
Related terms Urinary Tract Infections
Enrollment 136 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov